Systematic Review and Meta-Analysis of the Outcome of Different Treatments for Innominate Artery Stenosis or Occlusion

Abstract

The present study reported the outcomes of different treatments for innominate artery (IA) atherosclerotic stenosis or occlusion. We performed a systematic review of the literature (4 database searched; last search February 2022), including articles with ≥5 patients. We performed meta-analyses of proportions for different postoperative outcomes. Fourteen studies were included (656 patients; 396 underwent surgery, 260 endovascular procedures). IA lesions were asymptomatic in 9.6% (95% CI 4.6–14.6). Overall estimated technical success (TS) rate was 91.7% (95% CI 86.9–96.4); weighted TS rate was 86.8% (95% CI 75–98.6) in the surgical group (SG), 97.1% (95% CI 94.6–99.7) in the endovascular group (EG). Postoperative stroke in SG was 2.5% (95% CI 1–4.1) and 2.1% in EG (95% CI .3–3.8). Overall, 30-day occlusion was estimated .9% (95% CI 0–1.8) in SG and .7% (95% CI 0-1.7) in EG. Thirty-day mortality was 3.4% (95% CI .9–5.8) in SG and .7% (95% CI 0–1.7) in EG. Estimated mean follow-up after intervention was 65.5 months (95% CI 45.5–85.5) in SG and 22.4 months (95% CI 14.72–30.16) in EG. During follow-up, restenosis in SG were 2.8% (95% CI .5–5.1) and 16.6% (95% CI 5– 28.1) in EG. In conclusion, the endovascular approach seems to offer good short to mid-term outcomes, but with a higher rate of restenosis during follow-up.